Issue

Vol. 12 No. 1 (2024): 2024 Volume -12 - Issue 1

Date Log

Submitted
March 11, 2024
Published
March 11, 2024
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

A Comprehensive Review On Analytical Methods-For The Quantification Of Empagliflozin In Drug Product And Drug Substance

V. Sravan Kumar
Department of Pharmaceutical Analysis, Vignan Pharmacy College, Vadlamudi, 522213, Andhra Pradesh, India.
P. Srinivas Babu
Department of Pharmaceutics, Vignan Pharmacy College, Vadlamudi,522213, Andhra Pradesh, India.
B. Gnana Sri Siva Naga Lakshmi
Department of Pharmaceutical Analysis, Vignan Pharmacy College, Vadlamudi, 522213, Andhra Pradesh, India.
P. Parimala
Department of Pharmaceutical Analysis, Vignan Pharmacy College, Vadlamudi, 522213, Andhra Pradesh, India.
B. Moushmi
Department of Pharmaceutical Analysis, Vignan Pharmacy College, Vadlamudi, 522213, Andhra Pradesh, India.
U. Lavanya
Department of Pharmaceutical Analysis, Vignan Pharmacy College, Vadlamudi, 522213, Andhra Pradesh, India.
T. Sai Kiran
Department of Pharmaceutical Analysis, Vignan Pharmacy College, Vadlamudi, 522213, Andhra Pradesh, India.

Corresponding Author(s) : V. Sravan Kumar

sravankumarvaka@gmail.com

International Journal of Allied Medical Sciences and Clinical Research, Vol. 12 No. 1 (2024): 2024 Volume -12 - Issue 1

Abstract

Pharmaceutical analysis plays an important role in the quantification of drugs in pharmaceutical products and it employs a significant role in the analytical research and development and in quality control of finished products and drug substances and also in the bio analytical method development. Empagliflozin, a new oral anti-diabetic drug which is used to treat the type 2 diabetes and it is a selective sodium- glucose co transport–2[SGLT2] inhibitor by inhibiting the reabsorption of glucose from proximal tubules of the kidney and excretes as such through urine by SGLT-2 receptor inhibition. The main advantage of this gliflozin category is that they will improve the functioning of heart and kidneys of the patients who suffering from cardiovascular disease and chronic kidney diseases (CKD). Empagliflozin is available in tablet dosage forms with the strength of 10mg and 25mg. The current review article will provide the analytical data for the quantification of Empagliflozin in various pharmaceutical formulations and in biological samples by using different analytical methods like HPLC, UHPLC, LC MS/MS and UV- Visible Spectrophotometric methods.

Keywords

Empagliflozin Analytical method development SGLT-2 receptors CKD Cardiovascular disease
V. Sravan Kumar, P. Srinivas Babu, B. Gnana Sri Siva Naga Lakshmi, P. Parimala, B. Moushmi, U. Lavanya, & T. Sai Kiran. (2024). A Comprehensive Review On Analytical Methods-For The Quantification Of Empagliflozin In Drug Product And Drug Substance. International Journal of Allied Medical Sciences and Clinical Research, 12(1), 57–68. Retrieved from https://ijamscr.com/ijamscr/article/view/1458
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. Rohini M, Ajitha M. Stability Indicating Method Development And Validation For Determination Of Metformin And Empagliflozin In Bulk And Pharmaceutical Dosage Form By Rp-Hplc. World Journal Of Pharmaceutical Sciences. 2022 Jan 2:82-9. https://doi.org/10.54037/WJPS.2022.100108
  2. More Jd, Patil Sb, Chittam Kp, Patil Ms. The Review Article On–Analytical Method Development And Validation Of Oral Anti-Diabetics Pharmaceutical Dosage Form Based On Recent Literature. International Journal of Research Publication and Reviews, 2023; 4(4): 1305-1318.
  3. Maroky As, Sreenivas Sa, Lohitha K, Kumar Ev, Roja P, Sreeja K. Method Development And Validation For The Estimation Of Empagliflozin In Bulk Form And Marketed Tablet Dosage Form By Rp-Hplc. International Journal of Multidisciplinary Research and Growth Evaluation. 2022; 3(6):476-482. Available from: https://www.allmultidisciplinaryjournal.com/uploads/archives/20221213173226_F-22-83.1.pdf
  4. Naazneen S, Sridevi A. Development And Validation Of Stability Indicating Rp-Hplc Method For Simultaneous Estimation Of Empagliflozine And Linagliptin In Tablet Formulation. Der Pharmacia Lettre. 2016;8(17):57-65. Available from: https://www.stmaryscollegeofpharmacy.ac.in/pdf/Derpharmacia-lettre-Naazneen.pdf
  5. Unade Tt, Pawar Ak. New Validated Stability-Indicating Rp-Hplc Method For The Simultaneous Determination Of Metformin Hydrochloride, Linagliptin And Empagliflozin In Bulk And Pharmaceutical Dosage Forms. Int J App Pharm. 2022;14(2):68-76. Available from : https://www.academia.edu/download/101091586/43626.pdf
  6. Pathak S, Mishra P. Stability-Indicating Hplc-Dad Method For The Determination Of Empagliflozin. Future Journal Of Pharmaceutical Sciences. 2021 Aug 30;7(1):181. Available from: https://link.springer.com/article/10.1186/s43094-021-00329-w
  7. Kapoor G, Bhutani R, Dutta M, Sharma A, Khan F, Bhatt P. Future Technology Based Hplc Analytical Procedures And Pharmaceutical Description Of Empagliflozin. Journal Of Pharmaceutical Negative Results. 2022 Nov 17:1453-65. Available from:https://pnrjournal.com/index.php/home/article/view/3578
  8. Basak M, Gouru Sr, Bera A, Nagappan Kv. An A Rapid And Sensitive Rp-Hplc Method For The Quantitative Analysis Of Empagliflozin In Bulk And Pharmaceutical Dosage Form. International Journal Of Applied Pharmaceutics. 2019;11(5):60-5. Available from: https://pdfs.semanticscholar.org/1a64/2cbfe6ae6e0ae7605d6b372c6309ff8e2ea0.pdf
  9. Ahmad A, Maryam Z. Development And Validation Of Novel Stability Indicating Rp Hplc Method For Quantitative Estimation Of Empagliflozin In Tablets. Indian Journal Of Pharmacy & Drugs Studies. 2023 Feb 6:22-8. Available from: https://mansapublishers.com/index.php/ijpds/article/view/3748
  10. Burin Sl, Lourenço Rl, Doneda M, Müller Ei, Paula Fr, Adams Ai. Development Of An Hplc-Uv Method To Assay Empagliflozin Tablets And Identification Of The Major Photoproduct By Quadrupole Time-Of-Flight Mass Spectrometry. Journal Of Chromatographic Science. 2021 Jul;59(6):526-35. Available fom: https://academic.oup.com/chromsci/article-abstract/59/6/526/6105948
  11. Jaiswal Sh, Katariya Mv, Katariya Vr, Karva Gs, Koshe K. Validated Stability Indicating Hplc Method For Determination Of Process Related Impurities In Empagliflozin Drug Substances. World J Pharm Res. 2017 May 15;6(7):1025-37. Available fom: https://wjpr.s3.ap-south-1.amazonaws.com/article_issue/1498817415.pdf
  12. Hanif Am, Bushra R, Ismail Ne, Bano R, Abedin S, Alam S, Khan Ma, Arif Hm. Empagliflozin: Hplc Based Analytical Method Development And Application To Pharmaceutical Raw Material And Dosage Form. Pakistan Journal Of Medical Sciences. 2021 May 1;34(3):1081-7. Available from: https://doi.org/10.36721/PJPS.2021.34.3.SUP.1081-1087.1
  13. Shirisha V, Bolle K, Santosh I, Rao Kn, Rajeswar Dk. A New Simple Method Development, Validation And Forced Degradation Studies Of Empagliflozin By Using Rp-Hplc. International Journal Of Pharmacy And Biological Sciences. 2019;9(1):25-35.
  14. Manoel Jw, Primieri Gb, Bueno Lm, Giordani Cf, Sorrentino Jm, Dallegrave A, Paim Cs, Schapoval Ee, Garcia Cv, Steppe M. Determination Of Empagliflozin In The Presence Of Its Organic Impurities And Identification Of Two Degradation Products Using Uhplc-Qtof/Ms. Microchemical Journal. 2021 Feb 1;161:105795.
  15. Murugesan A, Mukthinuthalapati A. Novel Simplified Analytical Method For Stress Degradation Study Of Empagliflozin An Oral Anti-Diabetic Agent By Rp-Hplc Method. Acta Scientific Pharmaceutical Sciences (Issn: 2581-5423). 2021 Jan;6(1).
  16. Rao Ms, Rambhau Dk. Development And Validation For The Simultaneous Estimation In Of Metformin And Empagliflozin In Drug Product By Rp-Hplc. European Journal Of Biomedical And
  17. Pharmaceutical Sciences.
  18. ;5(2):404-10.
  19. Rohini M, Ajitha M. Stability Indicating Method Development And Validation For Determination Of
  20. Metformin And Empagliflozin In Bulk And Pharmaceutical Dosage Form By Rp-Hplc: Https://Doi.
  21. Org/10.54037/Wjps. 2022.100108. World Journal Of Pharmaceutical Sciences. 2022 Jan 2:82-9.
  22. El Sheikh, R., Hassan, W.S., Youssef, E., Hamdi, A.Y., Badahdah, N.A., Alzuhiri, M.E. And Gouda,
  23. A.A.E., 2020. Development And Validation Of Rapid Stability-Indicating High-Performance Liquid
  24. Chromatography Method For The Determination Of Linagliptin And Empagliflozin In Pure And
  25. Dosage Forms. Development, 13(4).
  26. Naazneen S, Sridevi A. Development And Validation Of Stability Indicating Rp-Hplc Method For
  27. Simultaneous Estimation Of Empagliflozine And Linagliptin In Tablet Formulation. Der Pharmacia
  28. Lettre. 2016;8(17):57-65.
  29. Unade Tt, Pawar Ak. New Validated Stability-Indicating Rp-Hplc Method For The Simultaneous
  30. Determination Of Metformin Hydrochloride, Linagliptin And Empagliflozin In Bulk And
  31. Pharmaceutical Dosage Forms. Int J App Pharm. 2022;14(2):68-76.
  32. Amin As, Mohamed Sf, Abo-Taleb Mm. Simultaneous For The Estimation Of Metformin And
  33. Empagliflozin In Pharmaceutical Dosage Form By Hplc Method. Journal Of Pharmacy And Biological
  34. Sciences. 2019;14(1):75-80.
  35. Marie Aa, Salim Mm, Kamal Ah, Hammad Sf, Elkhoudary Mm. Analytical Quality By Design Based
  36. On Design Space In Reversed-Phase-High Performance Liquid Chromatography Analysis For
  37. Simultaneous Estimation Of Metformin, Linagliptin And Empagliflozin. Royal Society Open Science.
  38. Jun 15;9(6):220215.
  39. Laxman B, Yojana K, Chaitali K, Shivam K, Sagar M, Godge Rk. A Rapid And Sensitive Stability
  40. Indicating Rp-Hplc Method Development For The Quantitative Analysis Of Empagliflozin &
  41. Linagliptin In Bulk & Synthetic Mixture.
  42. Bahgat Ea, Hashem H, Saleh H, Kamel Eb, Eissa Ms. Hplc-Dad Technique For The Quantification Of
  43. A Recently Approved Anti-Diabetic Triple Combination Along With Two Toxic Official Impurities:
  44. Toxicity Confirmation Aided By Molecular Docking Application. Bmc Chemistry. 2023 Dec;17(1):1-0.
  45. Kadam Gm, Puyad Al, Kalyankar Tm, Kshirsagar Rv. Reverse Phase Chromatographic Method Of
  46. Analysis For Assay And Content Uniformity Estimation Of Drug Sitagliptin, Metformin And
  47. Empagliflozin From Available Marketed Formulation. Oriental Journal Of Chemistry. 2021 Aug
  48. ;37(4).
  49. Wagh Kr, Jat Rk, Akhtar R. A Validated Stability Indicating Rp-Hplc Method For Simultaneous
  50. Estimation Of Metformin And Empagliflozine In Bulk And Pharmaceutical Dosage Form.
  51. Madhusudhan P, Reddy Mr, Devanna N. Rphplc Method Development And Validation For
  52. Simultaneous Determination Of Linagliptin And Empagliflozine In Tablet Dosage Form. International
  53. Advanced Research Journal In Science, Engineering And Technology. 2015;2(2):95-9.
  54. Kumar Dv, Rao Js. A New Validated Stability Indicating Rp-Hplc Method For Simultaneous Estimation
  55. Of Metformin Hydrochloride And Empagliflozin In Tablet Dosage Forms. Irjpms. 2018;1:16-22.
  56. Sharif S, Bashir R, Adnan A, Mansoor S, Ahmad I, Ch Ar, Tahir Ms. Stability Indicating, Ph And P K
  57. A Dependent Hplc–Dad Method For The Simultaneous Determination Of Weakly Ionizable
  58. Empagliflozin, Dapagliflozin And Canagliflozin In Pharmaceutical Formulations. Chromatographia.
  59. Dec;83:1453-65.
  60. Donepudi S, Achanta S. Validated Hplc-Uv Method For Simultaneous Estimation Of Linagliptin And
  61. Empagliflozin In Human Plasma. International Journal Of Applied Pharmaceutics. 2018;10(3):56-61.
  62. Mahendra S, Rajamani A, Yashodha A. Method Development And Validation For The Simultaneous
  63. Estimation Of Empagliflozin And Linagliptin In Bulk Form And Marketed Tablet Dosage Forms By
  64. Rp-Hplc.
  65. Hassib St, Taha Ea, Elkady Ef, Barakat Gh. Validated Liquid Chromatographic Method For The
  66. Determination Of (Canagliflozin, Dapagliflozin Or Empagliflozin) And Metformin In The Presence Of
  67. (1- Cyanoguanidine). Journal Of Chromatographic Science. 2019 Jul;57(8):697-707.
  68. Ahmad R, Hailat M, Jaber M, Alkhawaja B, Rasras A, Al-Shdefat Ra, Mallah Ey, Abu Dayyih W. Rp-
  69. Hplc Method Development For Simultaneous Estimation Of Empagliflozin, Pioglitazone, And
  70. Metformin In Bulk And Tablet Dosage Forms. Acta Pol. Pharm. Drug Res. 2021 May 1;78:305-15.
  71. Kothari Pp, Kawarkhe Ss, Surung Mp, Akotkar Vb. A Review On Method Development And Validation
  72. Of Stability Indicating Rp Hplc Method For Metformin And Empagliflozin. Gsc Biological And
  73. Pharmaceutical Sciences. 2023;24(1):310-8.
  74. Abou-Omar Mn, Kenawy M, Youssef Ao, Alharthi S, Attia Ms, Mohamed Eh. Validation Of A Novel
  75. Uplc-Ms/Ms Method For Estimation Of Metformin And Empagliflozin Simultaneously In Human
  76. Plasma Using Freezing Lipid Precipitation Approach And Its Application To Pharmacokinetic Study.
  77. Journal Of Pharmaceutical And Biomedical Analysis. 2021 Jun 5; 200:114078.
  78. Van Der Aart-Van Ab, Wessels Am, Heerspink Hj, Touw Dj. Simple, Fast And Robust Lc-Ms/Ms
  79. Method For The Simultaneous Quantification Of Canagliflozin, Dapagliflozin And Empagliflozin In
  80. Human Plasma And Urine. Journal Of Chromatography B. 2020 Sep 1;1152:122257.
  81. Patel Ma, Pandya P, Kothari S, Ameta Sc. Development And Validation Of Analytical Lc-Ms Method
  82. For Simultaneous Determination Of Oral Hypoglycemic Agents (Met, Dfz, Efz And Cfz) In
  83. Pharmaceutical Dosage Form.
  84. Ayoub Bm, Mowaka S, Elzanfaly Es, Ashoush N, Elmazar Mm, Mousa Sa. Pharmacokinetic Evaluation
  85. Of Empagliflozin In Healthy Egyptian Volunteers Using Lc-Ms/Ms And Comparison With Other Ethnic
  86. Populations. Scientific Reports. 2017 May 31;7(1):2583.
  87. Jagadeesh M, Kumar G. Development And Validation Of Empagliflozin In Human Plasma Using
  88. Nevirapine As Internal Standard By Liquid Chromatography-Tandem Mass Spectrometry. Mass
  89. Spectrometry.;6(S6):272-81.
  90. Kuoni S, Müller D, Simões-Wüst Ap, Steiner R. Simultaneous Lc-Ms/Ms Quantification Of Sglt2
  91. Inhibitors And Antipyrine In Medium And Tissue From Human Ex Vivo Placenta Perfusions. Journal
  92. Of Chromatography B. 2023 Aug 1;1228:123841.
  93. Sen Ak, Pandey H, Maheshwari Ra, Zanwar As, Velmurugan R, Sen Db. Novel Uv Spectroscopic
  94. Methods For Simultaneous Assessment Of Empagliflozin, Linagliptin And Metformin In Ternary
  95. Mixture. Indian J Pharm Educ Res. 2022 Oct 1;56(4):S669-81.
  96. Development And Validation Of Uv Spectrophotometric Method For Simultaneous Estimation Of
  97. Empagliflozin And Linagliptin In Bulk Drugs And Pharmaceutical Dosage Form Sachin S. Rane1 ,
  98. Rajesh Y.
  99. Chaudhari1 , Vijay R. Patil1 , Lokesh G. Barde2
  100. Baokar S, Patil R, Pandey An. Validated Method Development For The Simultaneous Estimation Of
  101. Empagliflozin, Linagliptin, And Metformin In Marketed Formulation Using Uv Vis Spectrophotometer.
  102. International Journal Of Pharmaceutical Research. 2020 Oct 1;12(4).
  103. Jyothirmai N, Nagaraju B, Anil Kumar M. Novel Uv And Visible Spectrophotometric Methods For The
  104. Analysis Of Empagliflozin A Type 2 Diabetic Drug In Bulk And Pharmaceutical Formulations. Journal
  105. De Afrikana. 2016;3(1):177-87.
  106. Mathew C, Varma S. Green Analytical Methods Based On Chemometrics And Uv Spectroscopy For The
  107. Simultaneous Estimation Of Empagliflozin And Linagliptin. Asian Journal Of Pharmaceutical Analysis.
  108. ;12(1):43-8.
  109. Sharma P, Kosanam S, Rao Ss. Development And Validation Of Q-Absorbance Ratio By Uv-
  110. Spectrophotometric Method For Simultaneous Estimation Of Metformin And Empagliflozin In Bulk
  111. And Combined Dosage Form. Journal Of Drug Delivery And Therapeutics. 2021 Apr 15;11(2-S):14-8.
Read More
Author biographies is not available.
Download
PDF
Statistic
Read Counter : 68 Download : 41